|Articles|July 20, 2022
mRNA 5’ cap characterization using LC-HRAM-MS
Author(s)Thermo Fisher Scientific
The 5’ capping is a CQA for mRNA vaccines and therapeutics, and needs to be fully characterized. Learn a sensitive, robust LC-HRAM-MS/MS method for identification and quantitation of 5’ cap.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Streamlining Procurement and Inventory Management Leads to Increased Productivity
3
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
4
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
5
